Abstract
Objective: to investigate the responses to mRNA COVID-19 vaccines in a cohort of immunosuppressed patients affected by immune-mediated inflammatory diseases (IMID).
Methods: we have measured humoral and cellular immunity using quantitative IgG anti-SARS-CoV-2 Spike antibody (anti-S-IgG), neutralization assays and specific interferon-gamma (IFN-g) release assay (IGRA) before and after the third dose of BNT162b2. The response of those on anti-CD20 (n = 18) was then compared with healthy controls (HC, n = 18) and IMID naïve to anti-CD20 drugs (n = 13).
Results: a third BNT162b2 dose is highly immunogenic in IMID patients naïve to anti-CD20, as 100% of the subjects seroconverted compared to the 55% in anti-CD20. The rate of IGRA response was of 79% in anti-CD20, 50% in IMID naïve to anti-CD20, 100% in HC. Among those who have seroconverted, IMID patients had significantly reduced anti-S-IgG and neutralization titers compared to HC, whereas no significant difference was observed when comparing anti-CD20 and HC. Furthermore, 13% of anti-CD20 and 7.7% of IMID were simultaneously negative for both neutralizing antibodies and IGRA after three doses.
Conclusion: these data draw attention to the immunogenicity of COVID-19 vaccination in treated IMID, taking specific groups into consideration for vaccination program.
Keywords: Autoimmune disease; BNT162b2; CD-20; COVID-19; IMID; Vaccination.
【저자키워드】 COVID-19, vaccination., BNT162b2, Autoimmune disease, CD-20, IMID, 【초록키워드】 neutralizing antibody, Inflammatory diseases, IgG, vaccination, immunogenicity, Neutralizing antibodies, spike, antibody, interferon, drug, anti-SARS-CoV-2, BNT162b2, Autoimmune disease, Cohort, COVID-19 vaccination, Neutralization assay, cellular immunity, response, Patient, group, Quantitative, humoral and cellular immunity, immunosuppressed patients, anti-CD20, neutralization titers, CD20, dose, Immunosuppressed, humoral, mRNA COVID-19 vaccine, Immune-mediated inflammatory diseases, significant difference, no significant difference, subject, healthy control, These data, naïve, healthy controls, immunogenic, mRNA COVID-19 vaccines, doses, neutralization titer, anti-S, neutralization assays, Immune-mediated inflammatory disease, IFN-g, affected, significantly, reduced, treated, seroconverted, immunosuppressed patient, of BNT162b2, 【제목키워드】 COVID-19 vaccine, therapy, mRNA, B-cell, cellular response, dose, humoral, depleting, of BNT162b2, patients treated,